Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalvès, Céline Gavoille, Coraline Dubot, Nicolás Isambert, Mario Campone, Olivier Trédan, M.A. Massiani, Cécile Mauborgne,

The Lancet Oncology · 2015 · 1.1K citations · 25 references

Concepts

References

25